Found: 6
Select item for more details and to access through your institution.
Biglycan reduces body weight by regulating food intake in mice and improves glucose metabolism through AMPK/AKT dual pathways in skeletal muscle.
- Published in:
- FASEB Journal, 2021, v. 35, n. 8, p. 1, doi. 10.1096/fj.202002039RR
- By:
- Publication type:
- Article
Effect of chitinase‐3‐like protein 1 on glucose metabolism: In vitro skeletal muscle and human genetic association study.
- Published in:
- FASEB Journal, 2020, v. 34, n. 10, p. 13445, doi. 10.1096/fj.202000925R
- By:
- Publication type:
- Article
ATP synthase inhibitory factor 1 (IF1), a novel myokine, regulates glucose metabolism by AMPK and Akt dual pathways.
- Published in:
- FASEB Journal, 2019, v. 33, n. 12, p. 14825, doi. 10.1096/fj.201901440RR
- By:
- Publication type:
- Article
Metformin overcomes resistance to cisplatin in triple-negative breast cancer (TNBC) cells by targeting RAD51.
- Published in:
- 2019
- By:
- Publication type:
- journal article
LIF, a Novel Myokine, Protects Against Amyloid-Beta-Induced Neurotoxicity via Akt-Mediated Autophagy Signaling in Hippocampal Cells.
- Published in:
- International Journal of Neuropsychopharmacology, 2019, v. 22, n. 6, p. 402, doi. 10.1093/ijnp/pyz016
- By:
- Publication type:
- Article
The myokine meteorin‐like (metrnl) improves glucose tolerance in both skeletal muscle cells and mice by targeting AMPKα2.
- Published in:
- FEBS Journal, 2020, v. 287, n. 10, p. 2087, doi. 10.1111/febs.15301
- By:
- Publication type:
- Article